Exicure (XCUR) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.12, +0.00% vs the prior close of $1.12.
- Volume 32.54K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
XCUR ends flat (+0.0%) to $1.12. Closed at $1.12, +0.00% vs the prior close of $1.12. Day range $1.08–$1.21, opened at $1.21.
XCUR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — XCUR ends flat (+0.0%) to $1.12
- Closed at $1.12, +0.00% vs the prior close of $1.12. Day range $1.08–$1.21, opened at $1.21.
- Volume was 32.54K shares, 0.8x its 50-day average of 38.53K.
- Price is -10.6% vs its 50-day average ($1.25) and -62.1% vs its 200-day average ($2.95).
- 52-week range $0.94–$9.48; today's close sits at 2% of that range, 88.2% below the 52-week high.
Oct 15, 2026 — XCUR slides 7.4% to $1.12
- Closed at $1.12, -7.44% vs the prior close of $1.21. Day range $1.10–$1.24, opened at $1.21.
- Volume was 20.60K shares, 0.5x its 50-day average of 38.68K — lighter than usual.
- Price is -10.9% vs its 50-day average ($1.26) and -62.4% vs its 200-day average ($2.98).
- 52-week range $0.94–$9.48; today's close sits at 2% of that range, 88.2% below the 52-week high.
Oct 14, 2026 — XCUR jumps 5.2% to $1.21, 4 up days in a row
- Closed at $1.21, +5.22% vs the prior close of $1.15. Day range $1.16–$1.26, opened at $1.16.
- Volume was 28.30K shares, 0.7x its 50-day average of 39.53K.
- Price is -4.3% vs its 50-day average ($1.26) and -59.6% vs its 200-day average ($3.00).
- 52-week range $0.94–$9.48; today's close sits at 3% of that range, 87.2% below the 52-week high.
- That makes 4 straight gains.
Oct 13, 2026 — XCUR jumps 5.5% to $1.15, 3 up days in a row
- Closed at $1.15, +5.50% vs the prior close of $1.09. Day range $1.09–$1.21, opened at $1.12.
- Volume was 27.80K shares, 0.7x its 50-day average of 40.01K.
- Price is -9.5% vs its 50-day average ($1.27) and -62.0% vs its 200-day average ($3.02).
- 52-week range $0.94–$9.48; today's close sits at 3% of that range, 87.9% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — XCUR jumps 3.8% to $1.09
- Closed at $1.09, +3.81% vs the prior close of $1.05. Day range $1.06–$1.10, opened at $1.09.
- Volume was 15.20K shares, 0.4x its 50-day average of 40.06K — lighter than usual.
- Price is -14.8% vs its 50-day average ($1.28) and -64.2% vs its 200-day average ($3.05).
- 52-week range $0.94–$9.48; today's close sits at 2% of that range, 88.5% below the 52-week high.
Oct 9, 2026 — XCUR jumps 5.0% to $1.05 on 9.0x normal volume
- Closed at $1.05, +5.00% vs the prior close of $1.00. Day range $0.94–$1.10, opened at $0.95.
- Volume was 316.50K shares, 9.0x its 50-day average of 35.01K — unusually heavy trading.
- Price is -18.6% vs its 50-day average ($1.29) and -65.8% vs its 200-day average ($3.07).
- 52-week range $0.94–$9.48; today's close sits at 1% of that range, 88.9% below the 52-week high.
Oct 8, 2026 — XCUR dips 2.0% to $1.00, a 52-week low
- Closed at $1.00, -1.96% vs the prior close of $1.02. Day range $0.99–$1.05, opened at $0.99.
- Volume was 14.80K shares, 0.4x its 50-day average of 35.25K — lighter than usual.
- Price is -23.1% vs its 50-day average ($1.30) and -67.7% vs its 200-day average ($3.09).
- 52-week range $0.99–$9.48; today's close sits at 0% of that range, 89.5% below the 52-week high.
Oct 7, 2026 — XCUR slides 5.6% to $1.02, a 52-week low
- Closed at $1.02, -5.56% vs the prior close of $1.08. Day range $1.00–$1.04, opened at $1.04.
- Volume was 9.20K shares, 0.3x its 50-day average of 36.00K — lighter than usual.
- Price is -22.4% vs its 50-day average ($1.31) and -67.3% vs its 200-day average ($3.12).
- 52-week range $1.00–$9.48; today's close sits at 0% of that range, 89.2% below the 52-week high.
Oct 6, 2026 — XCUR rises 0.9% to $1.08
- Closed at $1.08, +0.93% vs the prior close of $1.07. Day range $1.07–$1.11, opened at $1.11.
- Volume was 7.30K shares, 0.2x its 50-day average of 36.23K — lighter than usual.
- Price is -18.8% vs its 50-day average ($1.33) and -65.7% vs its 200-day average ($3.14).
- 52-week range $1.05–$9.48; today's close sits at 0% of that range, 88.6% below the 52-week high.
Oct 5, 2026 — XCUR slides 7.0% to $1.07, a 52-week low, 3 down days in a row
- Closed at $1.07, -6.96% vs the prior close of $1.15. Day range $1.07–$1.19, opened at $1.14.
- Volume was 17.70K shares, 0.5x its 50-day average of 36.93K — lighter than usual.
- Price is -20.3% vs its 50-day average ($1.34) and -66.2% vs its 200-day average ($3.17).
- 52-week range $1.05–$9.48; today's close sits at 0% of that range, 88.7% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — XCUR dips 2.5% to $1.15
- Closed at $1.15, -2.54% vs the prior close of $1.18. Day range $1.15–$1.18, opened at $1.17.
- Volume was 5.30K shares, 0.1x its 50-day average of 37.91K — lighter than usual.
- Price is -15.2% vs its 50-day average ($1.36) and -64.0% vs its 200-day average ($3.19).
- 52-week range $1.05–$9.48; today's close sits at 1% of that range, 87.9% below the 52-week high.
XCUR latest news & SEC filings
Every SEC filing by or about XCUR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $0 (prior year $0)
- Net income: -$1.12M (prior year -$2.62M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.18 (prior year -$0.41) (loss narrowed vs Jun 30, 2025)
Jul 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 17, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade XCUR
- Last results release: Mar 25, 2026 (8-K Item 2.02). Previous ones: Nov 7, 2025, Aug 8, 2025, Mar 18, 2025. Based on that rhythm, the next report is likely around Jun 24, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.47% (largest 7.7%). That is a volatile stock.
- Liquidity: about 31.80K shares (≈$35.62K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.12 vs a range of $0.94–$9.48 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 16 sales; latest: Hitron Inc. Exicure sold 258,367 shares on Jan 21, 2026.
- Latest filings: 8-K Sep 16, 2026; 10-Q Aug 14, 2026; 8-K Jun 30, 2026.
- Share count: 6.55M shares outstanding (Aug 13, 2026), +3.6% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
XCUR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.21 | 1.21 | 1.08 | 1.12 | 32.54K |
| Oct 15, 2026 | 1.21 | 1.24 | 1.10 | 1.12 | 20.60K |
| Oct 14, 2026 | 1.16 | 1.26 | 1.16 | 1.21 | 28.30K |
| Oct 13, 2026 | 1.12 | 1.21 | 1.09 | 1.15 | 27.80K |
| Oct 12, 2026 | 1.09 | 1.10 | 1.06 | 1.09 | 15.20K |
| Oct 9, 2026 | 0.95 | 1.10 | 0.94 | 1.05 | 316.50K |
| Oct 8, 2026 | 0.99 | 1.05 | 0.99 | 1.00 | 14.80K |
| Oct 7, 2026 | 1.04 | 1.04 | 1.00 | 1.02 | 9.20K |
| Oct 6, 2026 | 1.11 | 1.11 | 1.07 | 1.08 | 7.30K |
| Oct 5, 2026 | 1.14 | 1.19 | 1.07 | 1.07 | 17.70K |
| Oct 2, 2026 | 1.17 | 1.18 | 1.15 | 1.15 | 5.30K |
| Oct 1, 2026 | 1.17 | 1.18 | 1.11 | 1.18 | 4.40K |
| Sep 30, 2026 | 1.28 | 1.28 | 1.12 | 1.19 | 19.90K |
| Sep 29, 2026 | 1.20 | 1.20 | 1.14 | 1.14 | 29.30K |
| Sep 28, 2026 | 1.23 | 1.24 | 1.17 | 1.24 | 2.60K |
| Sep 25, 2026 | 1.22 | 1.23 | 1.21 | 1.22 | 3.20K |
| Sep 24, 2026 | 1.24 | 1.28 | 1.22 | 1.23 | 22.90K |
| Sep 23, 2026 | 1.25 | 1.29 | 1.23 | 1.24 | 9.30K |
| Sep 22, 2026 | 1.30 | 1.30 | 1.21 | 1.29 | 17.10K |
| Sep 21, 2026 | 1.24 | 1.34 | 1.21 | 1.26 | 32.10K |
About Exicure
Exicure (XCUR) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CHICAGO, IL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1698530.
XCUR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Josh Miller | Chief Accounting Officer | Feb 19, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jan 21, 2026 | Hitron Inc. Exicure | Sale | 258,367 | $4.50 |
| Jan 21, 2026 | Hitron Inc. Exicure | Sale | 258,367 | $4.50 |
| Jan 21, 2026 | Hitron Inc. Exicure | Sale | 258,367 | $4.50 |
| Jan 21, 2026 | Hitron Inc. Exicure | Sale | 258,367 | $4.50 |
| Jan 16, 2026 | Hitron Inc. Exicure | Sale | 734,747 | $4.50 |
| Jan 16, 2026 | Hitron Inc. Exicure | Sale | 734,747 | $4.50 |
| Jan 16, 2026 | Hitron Inc. Exicure | Sale | 734,747 | $4.50 |
| Jan 16, 2026 | Hitron Inc. Exicure | Sale | 734,747 | $4.50 |
| Jan 7, 2026 | Hitron Inc. Exicure | Sale | 741,272 | $4.50 |
| Jan 7, 2026 | Hitron Inc. Exicure | Sale | 741,272 | $4.50 |
| Jan 7, 2026 | Hitron Inc. Exicure | Sale | 741,272 | $4.50 |
| Jan 7, 2026 | Hitron Inc. Exicure | Sale | 741,272 | $4.50 |
| Dec 8, 2025 | Investment & Securities Co., Ltd. Sangsangin | Sale | 433,332 | $8.71 |
| Dec 8, 2025 | Investment & Securities Co., Ltd. Sangsangin | Sale | 433,332 | $8.71 |
| Dec 8, 2025 | Investment & Securities Co., Ltd. Sangsangin | Sale | 433,332 | $8.71 |
XCUR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $0 | $-4.95M | -0.79 | $-8.55M |
| Dec 31, 2024 | $500.00K | $-9.70M | -4.75 | $-2.91M |
| Dec 31, 2023 | $0 | $-16.91M | -10.55 | $-10.36M |
| Dec 31, 2022 | — | $-2.58M | -0.56 | $-35.66M |
| Dec 31, 2021 | — | $-64.10M | -21.70 | $-34.82M |
Latest balance sheet: total assets $11.40M, total liabilities $10.42M, cash $4.44M (as of Jun 30, 2026).
XCUR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Mar 25, 2026 | 8-K Item 2.02 (results) | $4.61 |
| Nov 7, 2025 | 8-K Item 2.02 (results) | $3.96 |
| Aug 8, 2025 | 8-K Item 2.02 (results) | $7.45 |
| Mar 18, 2025 | 8-K Item 2.02 (results) | $12.40 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $3.18 |
| Jun 17, 2024 | 8-K Item 2.02 (results) | — |
| Jun 6, 2024 | 8-K Item 2.02 (results) | — |
| May 16, 2024 | 8-K Item 2.02 (results) | — |
| Aug 11, 2023 | 8-K Item 2.02 (results) | — |
| Jul 14, 2023 | 8-K Item 2.02 (results) | — |
| Mar 27, 2023 | 8-K Item 2.02 (results) | — |
| Nov 14, 2022 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on XCUR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.